
FORM Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.2/10
Best for: Clients who want GLP-1 weight loss bundled with FORM's broader hair, peptide, and longevity menu
FORM scores highest on the strength of its clinical program — drug options and dosing support.
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Not disclosed
Coaching
Not disclosed
No insurance needed · Vetted by our editors
FORM by GBY is a Las Vegas-based telehealth platform offering physician-guided GLP-1 weight-loss programs alongside hair, peptide, and longevity treatments, prescribed through the Övie Health Group provider network. Compounded semaglutide starts at $299/month and compounded tirzepatide at $399/month, with a lower-strength microdose tirzepatide option at $199/month and oral dissolving-tablet versions also offered. FDA-approved Wegovy and Zepbound are available through a separate $95/month membership. Subscriptions can be canceled anytime with no long-term commitment.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Vetted alternatives to FORM
Direct Meds
Best for: listed for disclosure only — see its FDA warning and BBB complaints first
Editorial score · methodology
Maximus
Best for: men seeking compounded GLP-1 alongside testosterone optimization
Editorial score · methodology
Editorial score · methodology
FORM at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide, Wegovy® & Zepbound®
- Starting price
- $95/mo (Live-verified product page: "$299 per month")
- What's included
- Medication · Consult · Shipping
- FDA status
- No FDA warning letter on record
How we scored FORM
Each dimension is scored algorithmically from FORM’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
6.8/10At $199/mo, FORM runs about 18% above the $169 median for GLP-1 providers.
Effectiveness25%
8.5/10FORM offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes. FDA-approved brand options are available alongside compounded versions. An oral/needle-free option is offered for patients who avoid injections.
User Experience15%
7.4/10Online intake and platform experience — consult included in the price; 8 platform features disclosed.
Trust & Safety15%
7.3/10Core details confirmed by our editors; no FDA warning letters on file (last checked 2026-08-04).
Accessibility10%
6.1/10FORM's exact state footprint isn't published — confirm coverage in your state before signing up.
Support10%
5.9/10FORM provides standard clinician follow-up; no extended coaching or community program is disclosed.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this FORM review
Last checked August 2026- Confirmed current pricing across 7 dose/plan tiers
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: medium.
What to expect when you sign up with FORM
We walked FORM’s public signup flow in August 2026 to document the process — the steps, pricing transparency, and what’s required — before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Browse a treatment page (e.g. /semaglutide), where the drug, mechanism, and "$299 per month" price are shown before any signup step.
- 2Click "Start Now" — routes off-domain to a separate telehealth.formbygby.com patient portal.
- 3A "How it works" screen recaps the 3-step process (survey, provider review, pharmacy fulfillment) and confirms the selected product.
- 4Click Continue — the flow immediately requires creating an account (email + password) and accepting FORM's Terms, Privacy Policy, Returns Policy and Consent to Telehealth, PLUS the separate Privacy Policy and Terms of Service of an unnamed "partnering Provider Network," before any health question is asked.
- 5We stopped at this account-creation gate without entering an email, password, or any personal/health information.
- Price is visible on the public treatment page before you ever click "Start Now," which is more transparent than funnels that gate pricing behind intake.
- The account-creation gate arrives very early — before a single health question — and requires accepting a second set of legal documents from an unnamed "partnering Provider Network." Following that link identified the entity as Övie Health Group PLLC, a white-label telehealth prescriber network, which is not otherwise named on formbygby.com itself.
- Övie Health Group's own Telehealth Consent page lists its licensed coverage as 47 states + DC (naming each one; New Jersey is not among them), which does not match FORM's own Terms of Service claim of "48 States + Washington DC" (excluding only Alaska and Mississippi) — a real, unresolved discrepancy between the marketing site and the actual prescribing entity.
- We could not verify the true billing cadence (e.g., "per month" vs. "every 4 weeks") beyond the product-page marketing copy, because the cart/checkout lives inside the account-gated telehealth portal — a limitation of this walkthrough, not a confirmed defect.
FORM customer support
- hello@formbygby.com
GLP-1 medications FORM offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Pricing
Prices re-verified
Live-verified product page: "$299 per month"
Live-verified product page: "$399 per month"
Live-verified product page: "$215 per month"
Live-verified product page: "$299 per month"
Live-verified product page: "$199 per month"
Live-verified product page: "$95 monthly membership" — access/consult fee, medication cost via NovoCare not disclosed on-site
Live-verified product page: "$95 monthly membership" — access/consult fee, medication cost via LillyDirect not disclosed on-site
Ready to get started?
Plans and promotions change often — check FORM's current pricing and active discounts before you decide.
What we like
- LegitScript-verified pharmacy operations, confirmed via a live seal check on formbygby.com's own badge.
- Named compounding pharmacy partner (Vios Pharmacy, Livonia MI) disclosed in the Privacy Policy.
- Cancel-anytime subscriptions with no long-term commitment, per the FAQ.
- Oral dissolving-tablet (ODT) options for both semaglutide and tirzepatide, not just injectables.
- FDA-approved brand Wegovy® and Zepbound® available alongside compounded options.
- Broader wellness menu (NAD+, peptides, hair treatments) available under one account.
Watch-outs
- State coverage is unclear: FORM's own Terms claim 48 states + DC, but its prescribing partner's telehealth consent lists only 47 states + DC.
- Account creation (email + password) is required before any health question or price confirmation inside the intake flow.
- Wegovy®/Zepbound® "$95 monthly membership" is an access fee — the actual medication cost via NovoCare/LillyDirect is not disclosed on-site.
- Support is email-only (hello@formbygby.com); no phone number or published support hours found.
- No independent Trustpilot or Google review rating found on the site to verify any customer-satisfaction claims.
- Compounded medications are not FDA-approved, per the site's own disclosure.
Is FORM worth it? Our verdict
FORM positions itself around one thing: Clients who want GLP-1 weight loss bundled with FORM's broader hair, peptide, and longevity menu. It runs $199/month — a premium to the category, so the extras need to justify it. Its standout is a needle-free oral option, which very few providers offer.
Where FORM tries to set itself apart is the extras: Oral ODT Available, Wegovy® & Zepbound®, and LegitScript Verified.
How much FORM actually costs
- Compounded semaglutide — $299/month
- Compounded tirzepatide — $399/month
- Compounded semaglutide — $215/month
- Compounded tirzepatide — $299/month
- Compounded tirzepatide — $199/month
- Brand-name semaglutide — $95/month
For context, the typical ongoing price across the GLP-1 providers we track is around $169/month, so FORM's standing rate sits at the premium end.
For a direct comparison, RNK Health runs semaglutide and tirzepatide from $197/month — worth pricing against FORM before you commit.
Medications: what FORM prescribes
FORM prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro) — the two most-studied weight-loss molecules on the market today. You can choose FDA-approved brand-name pens or lower-cost compounded versions — the compounded route is how the monthly price stays down, with the trade-off that compounded drugs aren't FDA-approved as finished products.
FORM's needle-free oral option is a real draw if you've been avoiding a GLP-1 because of injections. Just set expectations on the science: oral and buccal delivery of these peptides is far less studied than the injectable versions the trials used, so treat it as a convenience option rather than a proven equal to the shot.
Who FORM is best for — and who should skip it
A good fit if you…
- are needle-averse and want a non-injectable option.
Look elsewhere if you…
- want the lowest total cost over 6–12 months — a flat-rate provider like bmiMD will likely beat the ongoing price.
- need to bill insurance — like most of this market, it's cash-pay.
Trust, safety, and medical oversight
We found no FDA warning letters on file for the provider. As with any compounded program, the most important step you can take is confirming which licensed pharmacy fills your prescription and what's in the formulation — we explain how in our scoring methodology.
Bottom line
FORM costs more than the budget end of the market, so it makes the most sense if its specific extras — the oral option especially matter to you. If they don't, you can likely get the same medication for less elsewhere. If you're comparison-shopping, Breeze Meds is one of the closest alternatives we track — worth a look before deciding.
The Bottom Line
FORM scores highest on the strength of its clinical program — drug options and dosing support.
Ready to start with FORM?
Starting at $199/month. See current pricing and start your free consultation.
FORM might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
- If the lowest possible monthly price is your top priority, consider Sesame Care (from $59/mo).
- If you want built-in coaching and behavior-change support, consider Found.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this FORM review:
Sources & methodology — as of August 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See FORM's current pricing
Plans start at $199/month. Start your free consultation to check eligibility and today's price.